United Kingdom · How much has 28X raised?
28X has raised $1.9M across 1 round since 2025.
United Kingdom · Funded startup
Who invested in 28X
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow 28X and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$1.9Mraised across 1 round since 2025, from 1 source
- Latest round
- Round, $1.9MAug 2025
- Investors
- 0
The rounds
- Aug 2025Round$1.9M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
28X filed 3 raises, $1.9M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Sept 2025$809KUK share allotment
- Aug 2025$470KUK share allotment
- Aug 2025$671KUK share allotment
Founders and team
From 28X's own website: 3 founders, 10 on the team.
- Alexandra EavisChief Product & Technology Officer - Genomics
- Dr. Bahaa Eddine SarroukhHead of the Philips Foundation
- Bavita RaiBoard Trustee of the British Gynaecological Cancer Society
- Carmen LopezSoftware engineer - KYAN Media
- Dr Temi AkitikoriMember of the 28X Medical Board
- Duncan RobertsonSenior Developer - KYAN Media
- James FaureAI / Lead MLOps Engineer
- Kate ThompsonCoFounder of BusinessFourZero & NED
- Pete WhiteCreative Director - KYAN
- Raphaël DénouxDirector of TV Partnerships, Samsung Europe
AdvisersDanielle KeiserKatherine ChurchLord David PriorMary O'ReillyMeghna Joshi-von Heyden
Quick answers about 28X
When did 28X last raise?
28X's most recent round, $1.9M, was in Aug 2025.
What was 28X's biggest round?
Its most recent round, $1.9M in Aug 2025, is also its largest on record.
Where is 28X based?
28X is based in the United Kingdom.
Companies like 28X
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.